DICE Therapeutics, Inc.
DICENASDAQHealthcare
$47.55
+$0.03(+0.06%)
Market Cap$2.3B
P/E Ratio—
52W High$47.9
52W Low$15.08
DICE Therapeutics, Inc. (DICE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DICE · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 8, 2023EPS Actual
-$0.74
Est. -$0.65 · -13.8%
Revenue
—
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 8, 2023
After Market Close
▼ Miss EPS
DICE reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 10, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 14, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 8, 2023 | -$0.69 | — | — | — | — | — |
| ▼ Q3 FY2023 | Aug 8, 2023 | -$0.65 | -$0.74 | -13.8% | — | — | — |
| ▲ Q2 FY2023 | May 11, 2023 | -$0.59 | -$0.54 | +8.5% | — | — | — |
| ▼ Q1 FY2023 | Mar 15, 2023 | -$0.49 | -$0.51 | -4.1% | — | — | — |
| ▲ Q4 FY2022 | Nov 9, 2022 | -$0.61 | -$0.55 | +9.8% | — | — | — |
| ▼ Q3 FY2022 | Aug 11, 2022 | -$0.56 | -$0.58 | -3.6% | — | — | — |
Q2 FY2024
May 10, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 8, 2023
EPS Actual
—
EPS Est.
-$0.69
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 8, 2023Miss
EPS Actual
-$0.74
EPS Est.
-$0.65
EPS Surpr.
-13.8%
Revenue
—
Q2 FY2023
May 11, 2023Beat
EPS Actual
-$0.54
EPS Est.
-$0.59
EPS Surpr.
+8.5%
Revenue
—
Q1 FY2023
Mar 15, 2023Miss
EPS Actual
-$0.51
EPS Est.
-$0.49
EPS Surpr.
-4.1%
Revenue
—
Q4 FY2022
Nov 9, 2022Beat
EPS Actual
-$0.55
EPS Est.
-$0.61
EPS Surpr.
+9.8%
Revenue
—
Q3 FY2022
Aug 11, 2022Miss
EPS Actual
-$0.58
EPS Est.
-$0.56
EPS Surpr.
-3.6%
Revenue
—
No analyst estimates available for DICE.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2023 | Aug 8, 2023 | -13.8% | $47.52 | $47.55 | +0.06% |
| ▲ Q2 FY2023 | May 11, 2023 | +8.5% | $37.83 | $36.74 | -2.88% |
| ▼ Q1 FY2023 | Mar 15, 2023 | -4.1% | $28.41 | $27.63 | -2.75% |
| ▲ Q4 FY2022 | Nov 9, 2022 | +9.8% | $32.39 | $30.76 | -5.03% |
| ▼ Q3 FY2022 | Aug 11, 2022 | -3.6% | $20.39 | $20.57 | +0.88% |
| ▲ Q2 FY2022 | May 12, 2022 | +7.4% | $16.34 | $16.34 | +0.00% |
| ▲ Q1 FY2022 | Mar 21, 2022 | +24.1% | $19.49 | $18.99 | -2.57% |
| ▲ Q4 FY2021 | Nov 12, 2021 | +360.0% | $30.08 | $29.41 | -2.23% |
Q3 FY2023+0.06%
Report Date
Aug 8, 2023
EPS Beat/Miss
-13.8%
Price Before
$47.52
Price After
$47.55
Q2 FY2023-2.88%
Report Date
May 11, 2023
EPS Beat/Miss
+8.5%
Price Before
$37.83
Price After
$36.74
Q1 FY2023-2.75%
Report Date
Mar 15, 2023
EPS Beat/Miss
-4.1%
Price Before
$28.41
Price After
$27.63
Q4 FY2022-5.03%
Report Date
Nov 9, 2022
EPS Beat/Miss
+9.8%
Price Before
$32.39
Price After
$30.76
Q3 FY2022+0.88%
Report Date
Aug 11, 2022
EPS Beat/Miss
-3.6%
Price Before
$20.39
Price After
$20.57
Q2 FY2022+0.00%
Report Date
May 12, 2022
EPS Beat/Miss
+7.4%
Price Before
$16.34
Price After
$16.34
Q1 FY2022-2.57%
Report Date
Mar 21, 2022
EPS Beat/Miss
+24.1%
Price Before
$19.49
Price After
$18.99
Q4 FY2021-2.23%
Report Date
Nov 12, 2021
EPS Beat/Miss
+360.0%
Price Before
$30.08
Price After
$29.41
Avg Beat Reaction-2.54%
Avg Miss Reaction-0.60%
Beat Rate5 / 8 quarters
Largest Move-5.03% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DICE ends December
DICE Therapeutics, Inc. (DICE) most recently reported earnings on August 8, 2023 for Q3 FY2023, posting EPS of $-0.74 — missing the analyst consensus of $-0.65 by -13.8%. The next DICE earnings date is expected around September 1, 2026.
Each quarter, investors track DICE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DICE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DICE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DICE earnings · 5 questionsDICE Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. DICE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DICE historically reports after market close (AMC).
DICE earnings datewhen is DICE earningsDICE next earnings datewhen does DICE report earningsDICE earnings calendar
▸ Source: FMP · DICE Therapeutics, Inc. SEC filings · US GAAP · DICE Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026